Trenchant Technologies Capital Corp. (AITTF)

OTCMKTS · Delayed Price · Currency is USD
0.0984
0.00 (0.00%)
Jun 11, 2026, 9:30 AM EST
Market Cap3.77M +324.9%
Revenue (ttm)n/a
Net Income-3.53M
EPS-0.05
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0984
Previous Close0.0984
Day's Range0.0984 - 0.0984
52-Week Range0.0061 - 0.2593
Beta-1.46
Analystsn/a
Price Targetn/a
Earnings Daten/a

About AITTF

Trenchant Technologies Capital Corp. is a private equity and venture capital firm specializing in early-stage, turnaround, special situation debt financing in private equity companies. The firm prefers to invest in novel technologies including Artificial Intelligence, Quantum Computing, and traditional businesses primarily in the medical, biomedical, and technology sectors. It seeks to invest in Canada. It invests in companies that are financially sound, with minimal debt and a clear pathway to significant revenue generation. The company was fo... [Read more]

Sector Financials
Founded 2016
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol AITTF

Financial Performance

Financial numbers in CAD Financial Statements

News

Trenchant Technologies Capital Corp. Completes Unwinding of Previous Limitless Quantum Acquisition and Corporate Updates

Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTCQB: AITTF) ("Trenchant" or the "Company") announces that it has completed the unwi...

7 weeks ago - Newsfile Corp

Trenchant Technologies Capital Corp. Announces Unwinding of Previous Limitless Quantum Acquisition

Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTCQB: AITTF) ("Trenchant" or the "Company") announces that it has entered into a shar...

2 months ago - Newsfile Corp

Trenchant Announces Closing of Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTC: AITTF) ("Trenchant" or the "Company") announces that, further to its News Release...

2 years ago - Newsfile Corp

GNQ Insilico's AI-Driven Digital Twin Platform Shows Promising Results in First Virtually Simulated Clinical Drug Trial

GNQ Insilico's ("GNQ") proprietary genomics-driven platform is leveraging Artificial Intelligence (AI) and Quantum Computing technologies to create "intelligent digital twins " of human patients that ...

2 years ago - Newsfile Corp